JP2008510685A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510685A5
JP2008510685A5 JP2007526129A JP2007526129A JP2008510685A5 JP 2008510685 A5 JP2008510685 A5 JP 2008510685A5 JP 2007526129 A JP2007526129 A JP 2007526129A JP 2007526129 A JP2007526129 A JP 2007526129A JP 2008510685 A5 JP2008510685 A5 JP 2008510685A5
Authority
JP
Japan
Prior art keywords
blood cancer
picornavirus
treating
subject
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007526129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510685A (ja
JP5054522B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2005/001257 external-priority patent/WO2006017914A1/en
Publication of JP2008510685A publication Critical patent/JP2008510685A/ja
Publication of JP2008510685A5 publication Critical patent/JP2008510685A5/ja
Application granted granted Critical
Publication of JP5054522B2 publication Critical patent/JP5054522B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007526129A 2004-08-20 2005-08-22 血液ガンを治療するための方法および組成物 Expired - Fee Related JP5054522B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2004904766 2004-08-20
AU2004904766A AU2004904766A0 (en) 2004-08-20 Treatment for hematologic cancers
AU2005901879 2005-04-14
AU2005901879A AU2005901879A0 (en) 2005-04-14 Methods and compositions for treatment of hematologic cancers
PCT/AU2005/001257 WO2006017914A1 (en) 2004-08-20 2005-08-22 Methods and compositions for treatment of hematologic cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012055445A Division JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2008510685A JP2008510685A (ja) 2008-04-10
JP2008510685A5 true JP2008510685A5 (enExample) 2008-09-04
JP5054522B2 JP5054522B2 (ja) 2012-10-24

Family

ID=35907185

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007526129A Expired - Fee Related JP5054522B2 (ja) 2004-08-20 2005-08-22 血液ガンを治療するための方法および組成物
JP2012055445A Pending JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012055445A Pending JP2012144549A (ja) 2004-08-20 2012-03-13 血液ガンを治療するための方法および組成物

Country Status (6)

Country Link
US (3) US8236298B2 (enExample)
EP (1) EP1793851B1 (enExample)
JP (2) JP5054522B2 (enExample)
KR (1) KR101295733B1 (enExample)
CA (1) CA2577692C (enExample)
WO (1) WO2006017914A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101295733B1 (ko) * 2004-08-20 2013-08-13 비랄리틱스 리미티드 혈액암의 치료방법 및 조성물
US20100111873A1 (en) 2007-02-20 2010-05-06 Russell Stephen J Treating cancer with viral nucleic acid
US20120052003A9 (en) * 2008-05-16 2012-03-01 Szalay Aladar A Microorganisms for preventing and treating neoplasms accompanying cellular therapy
WO2014201492A1 (en) * 2013-06-17 2014-12-24 Darren Raymond Shafren Methods for the treatment of bladder cancer
EP3110443A4 (en) 2014-02-27 2017-11-15 Viralytics Limited Combination method for treatment of cancer
ES2662822T3 (es) * 2015-03-04 2018-04-09 Scandion Oncology A/S Derivados de 4-amino-3-fenilamino-6-fenilpirazol[3,4-d]pirimidina para uso como inhibidores de la BCRP en tratamientos terapéuticos
KR20180136435A (ko) 2016-01-27 2018-12-24 온코루스, 인크. 종양 살상형 바이러스 벡터 및 그의 용도
US20190202886A1 (en) * 2016-05-11 2019-07-04 Ohio State Innovation Foundation ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
AU2017290828A1 (en) 2016-06-30 2019-01-24 Virogin Biotech Canada Ltd Pseudotyped oncolytic viral delivery of therapeutic polypeptides
US11612625B2 (en) 2017-07-26 2023-03-28 Oncorus, Inc. Oncolytic viral vectors and uses thereof
EP3731850A4 (en) 2017-12-29 2021-12-01 Oncorus, Inc. ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
CA3207359A1 (en) 2021-02-05 2022-08-11 Cecile Chartier-Courtaud Adjuvant therapy for cancer
JP2023085151A (ja) * 2021-12-08 2023-06-20 株式会社八神製作所 体外ホウ素中性子反応を用いた幹細胞の分取方法
EP4724111A2 (en) * 2023-06-08 2026-04-15 The Trustees Of Columbia University In The City Of New York Intracellular delivery of therapeutic cargos and viral rnas by engineered salmonella

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148621A0 (en) 1999-09-17 2002-09-12 Pro Virus Inc Oncolytic virus
AU2004202292B2 (en) 1999-11-25 2007-06-14 Viralytics Limited Method of Treating a Malignancy in a Subject
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
CA2412493C (en) * 2000-06-26 2010-11-09 Wellstat Biologics Corporation Purging of cells using viruses
HUP0400882A3 (en) * 2001-05-11 2011-01-28 Wellstat Biologics Corp Oncolytic virus therapy
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
US8114416B2 (en) * 2004-03-11 2012-02-14 Viralytics Limited Modified oncolytic viruses
TWI234446B (en) * 2004-04-06 2005-06-21 Wilmart Co Ltd Adjustable body-fitted sleeping bag
KR101295733B1 (ko) * 2004-08-20 2013-08-13 비랄리틱스 리미티드 혈액암의 치료방법 및 조성물

Similar Documents

Publication Publication Date Title
JP2008510685A5 (enExample)
CL2007003250A1 (es) Compuestos derivados de isoquinolina, inhibidores del virus de hepatitis c; composicion farmaceutica; y uso para el tratamiento de una infeccion por vhc.
NZ594105A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
WO2009029622A3 (en) Antiviral drugs for treatment of arenavirus infection
NO20090453L (no) Hepatitt C Virusinhibitorer
CL2008000751A1 (es) Compuestos derivados de cicloprop[d]indolo[2,1-a][2]benzacepina sustituidos con heterociclos; composicion farmaceutica; y uso en el tratamiento de infeccion por hepatitis c.
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
BRPI0511834A (pt) métodos por tratar hepatite c
WO2008021936A3 (en) Hepatitis c virus inhibitors
EP2124921A4 (en) SULFONYL SEMI-CARBAZIDES, CARBONYL SEMI-CARBAZIDS, SEMI-CARBAZIDS AND UREA, PHARMACEUTICAL COMPOSITIONS THEREOF, AND PROCESS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING ARENAVIRUS-ASSOCIATED INFECTIONS
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
JP2009511595A5 (enExample)
IL207468A (en) HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections
EA201270032A1 (ru) Ингибиторы репликации вирусов гриппа
EA201000105A1 (ru) Химические соединения
JP2010529118A5 (enExample)
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2007084435A8 (en) Methods for treating hepatitis c
WO2007014619A8 (en) Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
IL208070A (en) Production of a pharmaceutical composition containing myxoma virus, a pharmaceutical composition comprising myxoma virus and its use ex-vivo
WO2007041632A3 (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
CL2007003754A1 (es) Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc.
EP1827446A4 (en) SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND URETINS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHOD FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS WITH ARENA VIRUSES
IL190636A0 (en) Quinazoline derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments useful for treating or preventing flaviviridae infection